Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Polycystic Ovary Syndrome 7Breast Neoplasms 4Peripheral Nervous System Diseases 2Squamous Cell Carcinoma of Head and Neck 1Radiodermatitis 1Primary Ovarian Insufficiency 1Ototoxicity 1Neurotoxicity Syndromes 1Nervous System Diseases 1Mucositis 1Insulin Resistance 1Infertility, Female 1Infertility 1Hyperandrogenism 1Head and Neck Neoplasms 1Disease Progression 1Cisplatin Nephrotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1

Interventions

Tamoxifen 4Exercise 3pyrotinib 2abemaciclib 2Paclitaxel 2Metformin 2Letrozole 2Cyclophosphamide 2Control Groups 2Capecitabine 2Bupivacaine 2Aromatase Inhibitors 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1palbociclib 1iniparib 1exemestane 1durvalumab 1darolutamide 1Yoga 1Waiting Lists 1Vitamin D 1Tumor Burden 1Tretinoin 1Trastuzumab 1Tocopherols 1Thioctic Acid 1Surveys and Questionnaires 1Surgical Procedures, Operative 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Cancer Female × Thioctic Acid × Clear all
NCT06703593 2025-10-01

Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients

British University In Egypt

Phase 2 Completed
80 enrolled
Breast

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon âš¡